GL1X · GenesisL1 explorer

Research workbench

Reactive sites of an anticarcinogenic bowman-birk proteinase inhibitor are similar to other trypsin inhibitors

Analyse Reactive sites of an anticarcinogenic bowman-birk proteinase inhibitor are… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1PI2
Type
protein
Length
61 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Bowman-birk inhibitor (pi-II)
UniProt
P01064

Structure

x-ray diffraction · 1 distinct chain · 0% helix, 25% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABowman-birk inhibitor (pi-II)protein610% helix, 25% strandP01064

Modifications

Observed in the structure: 7 disulfide (disulfide).

Compared structures

  • 1PI2 · Reactive sites of an anticarcinogenic bowman-birk proteinase inhibitor are similar to… · the same entry in another collection · chain A against A, TM-score 1.00
  • P01064 · AlphaFold monomer V2.0 prediction for bowman-birk type proteinase inhibitor D-II (P01064) · a predicted model of the same protein · chain A against A, TM-score 0.89

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.